toxic multinodular goiter (Plummer's disease)
Jump to navigation
Jump to search
Epidemiology
- most common cause of hyperthyroidism in the elderly
- it occurs in <1/2 of patients with multinodular goiter
Clinical manifestations
- thyroid nodules & thyroid asymmetry
- cardiovascular manifestations tend to predominate
- differs from Grave's disease clinically:
- no associated ophthalmopathy
- no associated dermopathy
- hypermetabolism is less severe
Management
- beta-blockers:
- decrease beta-adrenergic mediated effects of thyrotoxicosis
- decrease peripheral conversion of T4 to T3
- indicated for all forms of thyrotoxicosis
- titrate according to heart rate
- propranolol 20-40 mg PO QID
- radioactive I-131 ablation
- subtotal thyroidectomy may be treatment of choice[2]
More general terms
Additional terms
References
- ↑ Manual of Medical Therapeutics, 28th ed, Ewald & McKenzie (eds), Little, Brown & Co, Boston, 1995, pg 469
- ↑ 2.0 2.1 Solomon DH, in: UCLA Intensive Course in Geriatric Medicine & Board Review, Marina Del Ray, CA, Sept 12-15, 2001
- ↑ Siegel RD, Lee SL Toxic nodular goiter. Toxic adenoma and toxic multinodular goiter. Endocrinol Metab Clin North Am. 1998 Mar;27(1):151-68. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/9534034